WILMINGTON, Del., October 8, 2026 — Ashland Inc. (NYSE: ASH) today announced the launch of forzango™ biofunctional, an active ingredient obtained by supercritical CO2 extraction from traceable, ethically-sourced and abundant condurango bark,
WILMINGTON, Del., October 1, 2026 – Ashland is spotlighting several new and expanded pharmaceutical solutions during CPHI Milan, October 6-8 (booth 1B42) and at AAPS PharmSci 360, New Orleans, LA, October 25-28, 2026 (booth 925).
Patented technology combines sustainability and performance, supporting next-generation formulations WILMINGTON, Del., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Continuing to scale its Transformed Vegetable Oils (TVO™) technology platform, Ashland Inc. (NYSE: ASH), today announced the global launch of
Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026. The event will begin promptly at 9:00 am ET and conclude by 11:00 am ET. Ashland leadership will provide an updated overview of the company’s innovative
Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland’s Technology Platforms, including their commercial
Commercialization follows strong interest from pharmaceutical developers worldwide WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable
WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock. The dividend will be payable on September 15, 2026, to stockholders of record at the close of
Sales of $497 million, up seven percent from the prior-year quarter Income from continuing operations of $41 million, or $0.89 per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $47 million, or $1.02 per diluted share Net income of $16
Company also forms Capital Allocation Advisory Committee WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), a global leader in additives and specialty ingredients, today announced the appointments of two new independent members of the Company Board of Directors and the
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, July 28, 2026. The company’s live webcast with securities analysts will include an executive summary and
